Leadership, Planning and Evaluation UPMC Hillman Cancer Center?s (HCC) planning and evaluation activities are well-developed and provide invaluable guidance to the HCC Senior Leadership Team (SLT): Director (Robert L. Ferris, MD, PhD), HCC Deputy Director (Edward Chu, MD), Deputy Director for Research Administration (Chad A. Ellis, PhD) and the Associate Directors for Basic Research (Shivendra Singh, PhD), Clinical Research (Antoinette Wozniak, MD), Population Sciences (Jian-Min Yuan, MD, PhD), Training and Education (Christopher Bakkenist, PhD), Catchment Area Research (Margaret Rosenzweig, PhD, CRNP-C, AOCN, FAAN), and Health Equity and Community Outreach & Engagement (Linda Robertson, RN, MSN, DrPH). Individually accomplished, with strong scientific and leadership achievements, they work collectively as the SLT HCC?s primary decision- making body for setting the Center?s overall strategic direction. The SLT provides direction in issues relevant to HCC operations, management, and policy, and oversees all research activities. This leadership team also sets budgetary and fiscal priorities and reviews HCC membership. In addition to the SLT, several key internal and external governance structures provide the primary means by which the HCC conducts ongoing planning and evaluation: the Research Executive Advisory Committee (REAC), Shared Resources Oversight Committee (SROC), Clinical Research Oversight Committee (CROC), Committee for Health Equity and Community Outreach & Engagement (CHECOE), Committee for Excellence in Cancer Education and Training (CECET), Facilities and Common Equipment Committee (FACE), and the Internal and External Advisory Boards. The REAC includes the SLT, Program and Shared Resources leadership, and key senior HCC members, and is an effective mechanism for information exchange among HCC stakeholders and serves as the primary forum for strategic planning. The External Advisory Board (EAB), comprising recognized leaders in basic, clinical, translational and population sciences, and cancer center administration, meets at least annually to review all aspects of HCC operations and new initiatives. Since his appointment, Dr. Ferris augmented EAB membership to better align with HCC scientific priorities and goals. Additional planning input is provided by retreats, other Center advisory committees, surveys and ad hoc external reviews. With careful planning and critical input from the different advisory groups, HCC leadership initiated an important strategic visioning and planning process, reorganized the research program structure, and created new committees to continuously improve oversight and governance. These coordinated teams provide critical advice and guidance, ensuring that the HCC effectively sets priorities and pursues objectives that promote its mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA047904-32
Application #
10024356
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-09-10
Project End
2025-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15260
Steinman, Justin; Epperly, Michael; Hou, Wen et al. (2018) Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways. Radiat Res 189:68-83
Yockey, Laura J; Jurado, Kellie A; Arora, Nitin et al. (2018) Type I interferons instigate fetal demise after Zika virus infection. Sci Immunol 3:
Chen, Jingci; Nagle, Alison M; Wang, Yu-Fen et al. (2018) Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors. J Biol Chem 293:3700-3709
Qin, Ye; Vasilatos, Shauna N; Chen, Lin et al. (2018) Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade. Oncogene :
Diaz-Perez, Julio A; Killeen, Meaghan E; Yang, Yin et al. (2018) Extracellular ATP and IL-23 Form a Local Inflammatory Circuit Leading to the Development of a Neutrophil-Dependent Psoriasiform Dermatitis. J Invest Dermatol 138:2595-2605
Evdokimova, Viktoria N; Gandhi, Manoj; Nikitski, Alyaksandr V et al. (2018) Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements. Oncotarget 9:13612-13622
Bissel, Stephanie J; Gurnsey, Kate; Jedema, Hank P et al. (2018) Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment. Retrovirology 15:17
Knickelbein, Kyle; Tong, Jingshan; Chen, Dongshi et al. (2018) Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer. Oncogene 37:4599-4610
Ancevski Hunter, Katerina; Socinski, Mark A; Villaruz, Liza C (2018) PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer. Mol Diagn Ther 22:1-10
Luu, Thehang; Kim, Kyu-Pyo; Blanchard, Suzette et al. (2018) Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer. Breast Cancer Res Treat 167:469-478

Showing the most recent 10 out of 1187 publications